Photosensitizers and light sources for photodynamic therapy of the Bowen's disease

Archives of Dermatological Research

Volumn 303, Issue 3, 2011, Pages 145-151

  Calin, M A ^a   Diaconeasa, A ^b   Savastru, D ^a   Tautan, M ^a  

^a NATIONAL INSTITUTE OF RESEARCH AND DEVELOPMENT FOR OPTOELECTRONICS INOE 2000   (Romania)

^b Grigore Alexandrescu Clinical Emergency Hospital for Children   (Romania)

Author keywords

Bowen's disease; Light; Photodynamic treatment; Photosensitizer

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER;

BOWEN DISEASE; CANCER REGRESSION; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LIGHT EMITTING DIODE; LIGHT IRRADIANCE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SHORT SURVEY; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

AMINOLEVULINIC ACID; BOWEN'S DISEASE; HUMANS; LASERS, SEMICONDUCTOR; LIGHT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 79955811858     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-011-1122-3     Document Type: Short Survey

References (31)

1. Attili SK, Lesar A, McNeill A, Camacho-Lopez M, Moseley H, Ibbotson S, Samuel IDW, Ferguson J (2009) An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Br J Dermatol 161(1):170-173. doi: 10.1111/j.1365-2133.2009.09096.x
2. Britton JE, Goulden V, Stables G et al (2005) Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Br J Dermatol 153(4):780-784 (Pubitemid 41415905)
3. Calzavara-Pinton PG, Venturini M, Sala R et al (2008) Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Br J Dermatol 159(1):137-144 (Pubitemid 351874478)
4. Clark C, Bryden A, Dawe R et al (2003) Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 19(3):134-141 (Pubitemid 36889801)
5. Cox NH, Eedy DJ, Morton CA (1999) Guidelines for management of Bowen's disease. Br J Dermatol 141:633-641 (Pubitemid 29512815)
6. Doffoel-Hantz V, Sparsa A, Marin B et al (2008) The value of photodynamic therapy in the treatment of Bowen's disease. Ann Dermatol Venereol 135(12):822-827
7. Dougherty TJ (1987) Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol 45:879-889
8. Fantini F, Greco A, Cesinaro AM et al (2008) Pathologic changes after photodynamic therapy for basal cell carcinoma and Bowen disease. Arch Dermatol 144(2):186-194
9. Fritsch C, Verwohlt B, Bolsen K, Ruzicka T, Goerz G (1996) Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism. Arch Dermatol Res 288(9):517-521 (Pubitemid 26280700)
10. Haas ER, de Vijlder HC, Sterenborg HJ et al (2009) Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. J Eur Acad Dermatol Venereol 23(5):571-572
11. Haddad R, Nesher E, Weiss J et al (2004) Photodynamic therapy for Bowen's disease and squamous cell carcinoma of the skin. Photodiagn Photodyn Ther 1(3):225-230 (Pubitemid 40614468)
12. Holt PJ (1988) Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol 119:231-240
13. Kim YJ, Kang HY, Lee ES, Kim YC (2007) Photodynamic therapy for treatment of Bowen's disease. Korean J Dermatol 45(3):237-241. http://koreamed.org/ SearchBasic.php?RID=0048KJD%2F2007.45.3.237&DT=1&QY= %22Korean+J+Dermatol%22+%5BJTI%5D++AND+2007+%5BDPY%5D+AND+Mar+%5BDPM%5D
14. Lehmann P (2007) Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 156(5):793-801
15. Mackenzie-Wood A, Kossard S, de Launey J et al (2001) Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 44:462-470 (Pubitemid 32199966)
16. Morton CA (2007) Methyl aminolevulinate: actinic keratoses and Bowen's disease. Dermatol Clin 25(1):81-87
17. Morton CA, Whitehurst C, McColl JH et al (2001) Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 137(3):319-324 (Pubitemid 32240786)
18. Morton CA, Whitehurst C, Moore JV, MacKie RM (2000) Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 143(4):699-700
19. Morton CA, Whitehurst C, Moseley H et al (1995) Development of an alternative light source to lasers for photodynamic therapy: 3. Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer. Lasers Med Sci 10(3):165-171
20. Parlette EC (2004) Red light laser photodynamic therapy of Bowen's disease. J Drugs Dermatol 3:S22-S24. http://findarticles.com/p/articles/mi- m0PDG/is-6-3/ai-n12418329/
21. Patel G, Goodwin R, Chawla M et al (2006) Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 54:1025-1032
22. Puizina-Ivic N, Zorc H, Vanjaka-Rogosic L, Miric L, Persin A (2008) Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy. Coll Antropol 32(Suppl 2):67-73. http://www.ncbi.nlm.nih.gov/pubmed/19138010
23. Salim A, Leman JA, Mccoll JH et al (2003) Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 148(3):539-543 (Pubitemid 36461334)
24. Soga F, Hanada K, Ueda E et al (2005) Photodynamic therapy using topical 5-aminolevulinic acid for Bowen's disease. Rinsho Derma 47(7):923-927. http://sciencelinks.jp/j-east/article/200521/000020052105A0676130.php
25. Stone N, Burge S (1999) Bowen's disease of the leg treated with weekly pulses of 5% fluorouracil cream. Br J Dermatol 140:987-988 (Pubitemid 29238495)
26. Tan B, Sinclair R, Foley P (2004) Photodynamic therapy for subungual Bowen's disease. Australas J Dermatol 45(3):172-174 (Pubitemid 39071030)
27. Thestrup-Pedersen K, Ravnborg L, Reymann F (1988) Morbus Bowen. Acta Derm Venereol 68:236-239
28. Tualle JM, Gelebart B, Tinet E et al (1996) Real time optical coefficient evaluation from time and space resolved measurements in biological tissues. Opt Commun 124:216-221 (Pubitemid 126386283)
29. Varma S, Wilson H, Kurwa HA et al (2001) Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 144(3):567-574 (Pubitemid 32232013)
30. Wong TW, Sheu HM, Lee JY, Fletcher RJ (2001) Photodynamic therapy for Bowen's disease (squamous cell carcinoma in situ) of the digit. Dermatol Surg 27(5):452-456 (Pubitemid 32436336)
31. Xu S, Wang X, Xu W et al (2002) Evaluation of photodynamic therapy of skin cancers with δ-aminolevulinic acid. Chin Med J 115(8):1141-1145 (Pubitemid 34947329)